What is the iCMLf?

The International CML Foundation (iCMLf) is a Foundation established in 2009 by a group of hematologists with a strong interest in CML. Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales, however our charter is global.

What are our aims and priorities?

The aims of the International CML Foundation (iCMLf) are to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML. There are numerous activities that could come within this broad vision but the initial focus is to meet the needs in CML that are not already being met by other groups, particularly those needs that are best addressed by a global organisation.

The iCMLf has three main priorities:

1. Improve access to world-class CML education and best practice
2. Increase the availability of CML testing for accurate diagnosis and monitoring. Through this we can increase access to the best possible therapies
3. Provide an online, global communication network for physicians and scientists working with CML

All our activities improve the lives of people with CML in the areas we reach. The ultimate vision of the iCMLf is that through the work to prevent and cure CML we can eradicate the disease.

What are our guiding principles?

• A focus on chronic myeloid leukemia and related disorders
• A truly independent not-for-profit foundation
• Collaboration with, but independence from, the pharmaceutical industry
• A global foundation with broad representation from all geographic regions
• Priorities and policies determined by hematologists and scientists involved in CML research and patient care
• Close consultation and cooperation with CML patient groups
• Active collaborations with key national and regional leukemia groups

Who is the iCMLf for?

Everybody with an interest in CML! However, while we collaborate closely with CML patient groups, our primary goal is to assist physicians and scientists managing and researching CML.

How is the iCMLf governed and financed?

The iCMLf has:

•  A Board of Directors
•  A Scientific Advisory Board - including representation of patient advocacy groups
•  36 National Representatives
•  Supporters